Demonstration of a sucrose-derived contrast agent for magnetic resonance imaging of the GI tract
β Scribed by Martinez, Gary V.; Navath, Suryakiran; Sewda, Kamini; Rao, Venkataramanarao; Foroutan, Parastou; Alleti, Ramesh; Moberg, Valerie E.; Ahad, Ali M.; Coppola, Domenico; Lloyd, Mark C.; Gillies, Robert J.; Morse, David L.; Mash, Eugene A.
- Book ID
- 122581566
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 476 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
A scaffold bearing eight terminal alkyne groups was synthesized from sucrose, and copies of an azide-terminated GdβDOTA complex were attached via copper(I)-catalyzed azide-alkyne cycloaddition. The resulting contrast agent (CA) was administered by gavage to C3H mice. Passage of the CA through the gastrointestinal (GI) tract was followed by T
1-weighted magnetic resonance imaging (MRI) over a period of 47h, by which time the CA had exited the GI tract. No evidence for leakage of the CA from the GI tract was observed. Thus, a new, orally administered CA for MRI of the GI tract has been developed and successfully demonstrated.
π SIMILAR VOLUMES
Nanometer-sized colloidal particles (nanoparticles) have been extensively used in biomedical applications as a result of their many useful electronic, optical, and magnetic properties that are derived from their nanometer size and composition. [1] Semiconductor nanoparticles (also known as quan-tum